Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.8.0.1
Stockholders' Equity
9 Months Ended
Sep. 30, 2017
Equity [Abstract]  
Stockholders' Equity

10.       Stockholders’ Equity

 

Investment Agreement

 

On February 7, 2017, the Company entered into a Stock Purchase Agreement with Johnson Controls pursuant to which the Company issued and sold to a wholly-owned subsidiary of Johnson Controls International plc, (“Johnson Controls”), 939,005 shares of its common stock at $11.33 per share for the gross proceeds of approximately $10.6 million. Costs incurred in connection with the transaction, primarily legal fees, totaled approximately $167,000. The Stock Purchase Agreement includes customary representations, warranties, and covenants by Johnson Controls and the Company, and an indemnity from the Company in favor of Johnson Controls.

 

In connection with the investment transactions, the Company also entered into an Investors Rights Agreement dated February 7, 2017 with Johnson Controls pursuant to which the Company granted Johnson Controls customary demand and piggyback registration rights, limited board observation rights and limited preemptive rights allowing Johnson Controls the right to purchase its proportional share of certain future equity issuances by the Company. The board observation and preemptive rights shall expire on the earlier of (i) such time as Johnson Controls no longer owns 50% of the acquired shares or (ii) the termination of both the Tolling/Lead Purchase Agreement and Equipment Supply Agreement.

 

There were no sales commissions paid by the Company in connection with the sale of its common shares to Johnson Controls.

 

Warrants exercised

 

During the nine months ended September 30, 2017, 1,175,796 shares were issued pursuant to cash and cashless warrant exercises as detailed below. Generally, the warrants specify using the preceding five-day average of closing prices for the Company’s common stock in the calculation of common stock to be issued pursuant to a cashless exercise.

 

Date of     Average Closing           Warrant     Common  
Warrant     Market Price     Exercise Price     Shares     Shares  
Exercise     Per Share     Per Share     Exercised     Issued  
                           
  2/10/2017     $ 11.016     $ 0.0034375       392,728       392,605  
  2/13/2017     $ 13.062     $ 3.00       25,119       19,349  
  2/13/2017     $ 13.062     $ 6.00       72,420       39,154  
  2/15/2017     $ 16.768     $ 6.00       65,177       41,856  
  2/16/2017     $ 16.768     $ 6.00       35,000       22,470  
  3/17/2017     $ 20.262     $ 6.00       2,500       2,500  
  3/20/2017     $ 20.304     $ 3.00       226,068       192,666  
  3/20/2017     $ 20.304     $ 6.00       586,596       413,253  
  4/3/2017     $ 19.148     $ 0.0034375       43,636       43,628  
  4/11/2017     $ 17.920     $ 6.00       12,500       8,315  
                                     
                          1,461,744       1,175,796  

  

Warrants outstanding

 

Warrants to purchase shares of the Company’s common stock at a weighted average exercise price of $8.45 per share are as follows.

 

 

Exercise Price     Expiration     Shares Subject to purchase  
per Share     Date     at September 30, 2017  
               
$ 7.12       5/18/2018       702,247  
$ 9.00       5/18/2019       1,605,131  
$ 10.00       11/21/2019       33,450  
                  2,340,828  

  

Stock based compensation

 

The stock-based compensation expense attributable to option grants was allocated as follows: 

 

    Three months ended September 30,     Nine months ended September 30,  
    2017     2016     2017     2016  
Cost of product sales   $ 17     $     $ 41     $  
Research and development cost     62       120       222       226  
General and administrative expense     46       40       329       672  
Total   $ 125     $ 160     $ 592     $ 898  

 

The following assumptions were used in the Black-Scholes-Merton pricing model to estimate the fair value of options granted during the periods presented.

 

    Three months ended September 30,     Nine months ended September 30,  
    2017     2016     2017     2016  
                         
Expected stock volatility     70.7% - 71.4 %     72.9% - 73.9 %     70.7% - 72.7 %     72%-80 %
Risk free interest rate     1.50% - 1.65 %     0.92% - 1.02 %     1.38% - 1.79 %     0.92%-1.77 %
Expected years until exercise     3.5       3.5       2.5-3.5       2.5-3.5  
Dividend yield     0 %     0 %     0 %     0 %

  

The Company issued 247,976 and 283,310 shares of common stock for the three and nine months ended September 30, 2017, respectively, upon stock option exercises.

 

Restricted Stock Units

 

In July 2017, the Company granted 49,751 restricted stock units (RSUs) with a grant date fair value of $581,000 to its Chief Financial Officer as part of his employment agreement. 16,584 RSUs will vest on each July 31, 2018 and July 31, 2019 and the remaining 16,583 RSU’s will vest on July 31, 2020.